Who we are
MUUTAA Inc. is a private healthcare AI company focused on improving operational efficiencies for our partners throughout the Rx medication development and delivery chain. MUUTAA envisions a world where medication reaches the consumer with speed, precision, and sustainable simplicity
MUUTAA democratizes the use of artificial intelligence through integration into standard operational workflows. The technological benefits can now be leveraged to solve real-world medication issues and positively impact patient care
What we do
Barry Holleman, healthcare executive with more than 20 years of experience in information technology in the healthcare and life sciences sector, Barry has developed expertise in drug lifecycle management and the traceability of drugs. After leading Cardinal Health's Canadian technology arm for more than 12 years, Barry has enabled medical technology start-ups to become commercially viable. In recent years, Barry has worked with the world's leading suppliers of traceability technologies. In particular, contributing to providing the health sector in Europe with the knowledge and products needed to implement the EU-FMD Directive (Falsified Medicines Directive). Associated with the Institute of Logistics at the University of Hull, Barry keeps abreast of research and development activities on supply chain management and logistics.
Korina Fischer, entrepreneur and experienced business leader with 20+ years in world-class health technology companies; trilingual, internationally oriented. Korina is highly committed, recognized for her business acumen and ability to mobilize resources. As Vice President, Healthcare for OPTEL Group, she was responsible for leading Optel's diversification strategy in the hospital and commercial pharmacy segment, including marketing, product and international sales team management dedicated to the business unit. At B-TEMIA (inventor of the biomechanical walking assistance device) and Cardinal Health (inventor of a bedside computer system) Korina developed a deep understanding of the healthcare IT ecosystem, decision-making structures and processes, pharmaceutical and medical device supply chains, reimbursement policies, regulatory affairs, clinical studies and relationship management with research centers and opinion leaders.
The MUUTAA founders saw specific opportunities for the application of artificial intelligence in the healthcare arena. Professionals with extensive workflow experience in the field of drug development, tracking and delivery, combined with high-caliber technology partners in health data management and artificial intelligence form the extraordinary MUUTAA team. MUUTAA is commercially active and has development capabilities on three continents